Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand ...

The stock's rise snapped a four-day losing streak.

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Troy Tazbaz, director of the Food and Drug Administration’s Digital Health Center of Excellence, said Friday in a LinkedIn post that he is leaving the agency effective immediately. Tazbaz led the ...

The Arden Theatre Company’s world premiere of the play Holy Grail of Memphis by Philly playwright Michael Hollinger examines the legacy of these recordings and raises the question: Who does this music ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

While Illumina completed the takeover of Grail last September, it has maintained the business as a separate subsidiary company while it waits for the outcome of antitrust reviews in the US and Europe.

GRAIL's founding was likely driven by Illumina's desire to realize more value from its NGS technology and a realization that costs and technological capabilities were reaching a point where liquid ...

Grail spun off from Illumina last year, and is developing a number of early detection cancer screening products. Last week, Grail said it sees fiscal 2025 sales of its Galleri blood test up 20% to ...

Abbott expects to launch its first pulsed field ablation (PFA) device outside of the U.S. in 2025, CEO Robert Ford told investors on Wednesday. A company spokesperson said Abbott expects to receive a ...